Lek Takeover: Shareholders Close the Door on Novartis
Ljubljana, 27 September - Shareholders of Slovenian drug-maker Lek have rejected changes to the company's statute that would allow Swiss pharmaceutical company Novartis to acquire the Ljubljana-based company.
The rest of this news item is available to subscribers.
The news item consists of 1.651 characters (without spaces) or 320 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.